https://nusano.com/



Radioisotopes in Oncology: Targeting Cancer at the
Atomic Level



Cancer treatment can feel overwhelming, daunting, and in a way confusing.
Traditional methods like chemotherapy and radiation often damage healthy
cells while trying to kill cancerous cells, and it’s a tough battle, both for patients
as well as doctors. However, what if cancer treatment could be done with laser
precision right at the atomic level? No, this is not science fiction; it’s the promise
of medical radioisotopes in oncology.

A Brief Overview of Radioisotopes
At their very core, radioisotopes are unstable atoms that release radiation.
While that might sound dangerous, in the right hands, this radiation can be a
powerful tool for treating cancer. Doctors can now use radioisotopes to deliver
targeted therapy, like small missiles at the atomic level that destroy the cancer
cells and leave healthy tissues untouched.

This method is known as Targeted Radionuclide Therapy (TRT), and it’s changing
the way we fight cancer. Unlike traditional therapies, TRT uses medical
radioisotopes that are linked to molecules that specifically seek out cancer cells.

https://nusano.com/nusano-and-glytherix-announce-lutetium-177-supply-agreement/


https://nusano.com/nusano-announces-isotope-availability/


https://nusano.com/



Once they reach their target, the isotopes release radiation to destroy the cells
from the inside.

How do Lu-177 and AC-225 Work?
Two of the most talked-about isotopes in cancer treatment today are Lutetium-
177 (Lu-177 and Actinium-225 9Ac-225). These are heavy hitters in the world of
TRT therapy, and here’s a brief on why they work so efficiently:

• Lu-177 emits beta particles and has shown excellent results in treating
neuroendocrine tumors and prostate cancer. It’s already FDA-approved
for several types of cancers. If you are a clinic or research center in the
States, finding a trusted Lu-177 supplier in the USA is crucial because the
results are effective, and the demand is skyrocketing.

• On the other hand, Ac-225 is a part of the newer wave of alpha emitters.
It is incredibly potent, as just a few atoms can do serious damage to a
cancer cell. Besides, as research advances, reliable Ac-225 supplier
networks are also becoming vital to scale up this treatment option.

From Production to the Patient
You might have questions if medical radioisotopes are so effective, why are they
not being used more extensively in cancer treatment? Well, the answer hinges
on radioisotope production. Without a stable and efficient production process,
hospitals can’t get the isotopes in a timely manner, and patients miss out on
potentially life-saving treatment. Unfortunately, global production is still
limited, and many isotopes are imported, creating supply chain issues and high
costs.

That's why countries, including the U.S., are ramping up investments in local
supply chains to support the growing clinical needs and research, now it’s not
just about science, it’s also about logistics, infrastructure, and timely action.

Conclusion
As we move deeper into the age of precision medicine, medical radioisotopes
will likely play a starring role. They offer a potent mix of specificity, effectiveness,
and minimal side effects, which is something that every cancer patient hopes
for. However, to bridge the gap or reduce the disruption in the medical
radioisotope supply chain, Nusano is leading the charge, and pioneering next-

https://nusanous.blogspot.com/2025/06/radioisotopes-in-oncology-targeting.html


https://nusanous.blogspot.com/2025/06/radioisotopes-in-oncology-targeting.html



gen production technologies to make life-saving isotopes more accessible than
ever.

Contact the team at Nusano today to learn how their cutting-edge solutions are
shaping the future of cancer care, atom by atom.


Source: https://nusanous.blogspot.com/2025/06/radioisotopes-in-oncology-
targeting.html